Amplifon, new dimension: takes over GN listening to for two.3 billion | EUROtoday

Listen to the audio model of the article

Amplifon lands the most important transformative acquisition in its historical past, making a $3.3 billion, vertically built-in international participant in audiology. It does so by taking on Gn Hearing, a Danish firm that produces and markets an entire portfolio of listening to options globally, thus going again to its historic core enterprise. The operation values ​​Gn Hearing at roughly 2.3 billion euros: on the closing, 1.69 billion in money (assured by a bridge mortgage) and 56 million Amplifon shares can be paid to the GN holding firm (making GN the second largest shareholder of Amplifon after Ampliter, with a 16% stake). Based on 2025 outcomes, the brand new group may have mixture revenues of roughly 3.3 billion euros and an mixture pro-forma adjusted Ebitda of roughly 830 million, with a margin of roughly 25 p.c.

«It is a turning level for Amplifon – explains CEO Enrico Vita -. The objective is to seriously change the way forward for the listening to care sector globally, creating important long-term worth for all stakeholders. We will create a vertically built-in international chief in audiology, with a presence in additional than 100 international locations, glorious industrial capabilities and an unmatched industrial community.”

At closing (expected by the end of the year) the pro-forma financial leverage (net financial position/adjusted Ebitda) will be approximately 3x (excluding net synergies). A capital increase of up to a maximum of 750 million euros is also expected. Upon hearing the news of the operation, Amplifon’s stock lost over 7%, falling below 10 euros: the value of the shares has practically halved in the last twelve months.

In the financial year ended 31 December 2025, GN Hearing generated revenues of 7.2 billion Danish crowns (approximately 1 billion euros) and pro-forma adjusted Ebitda carve-out (i.e. with the spin-off of GN Hearing from GN) of 1.6 billion Danish crowns (approximately 220 million euros), with a margin on revenues of approximately 23%. GN Hearing has a very diversified revenue profile globally: America 49%, Europe 28% and Rest of the World 23%.

Synergies forecast at Ebitda stage are 60-80 million by the tip of 2029, primarily deriving from the internationalization (insourcing) of Amplifon’s listening to assist volumes. Non-recurring prices regarding the combination are anticipated to be within the order of 80 million euros to be incurred within the subsequent 2-3 years from closing.